Anna Lantz MD, PhD

Anna Wallerstedt Lantz is an Associate Professor and Specialist in Urology at Karolinska University Hospital Solna, focusing on the detection and treatment of prostate cancer, combining clinical work with independent research at Karolinska Institutet.

Anna Lantz defended her thesis "Outcomes after surgical treatment of localized prostate cancer with a focus on urinary incontinence and short-term complications" in March 2015 at Karolinska Institutet. From 2016 to 2018 she undertook postdoctoral studies at the Department of Medical Epidemiology and Biostatistics within the STHLM studies with a focus on improved detection of prostate cancer, setting up the STHLM3AS trial as Principal Investigator. During 2019-2020 Anna Lantz undertook international postdoctoral studies at Icahn School of Medicine, Mount Sinai Hospital in New York.